ClinVar Miner

Submissions for variant NM_178012.5(TUBB2B):c.908G>A (p.Cys303Tyr)

dbSNP: rs2113819019
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 2
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Department of Clinical Genetics, Copenhagen University Hospital, Rigshospitalet RCV002226852 SCV002505738 likely pathogenic Complex cortical dysplasia with other brain malformations 7 2021-08-01 criteria provided, single submitter clinical testing
Broad Center for Mendelian Genomics, Broad Institute of MIT and Harvard RCV002226852 SCV005045251 likely pathogenic Complex cortical dysplasia with other brain malformations 7 2024-05-22 criteria provided, single submitter curation The heterozygous p.Cys303Tyr variant in TUBB2B was identified by our study in 2 siblings with cortical dysplasia, complex, with other brain malformations 7. Trio exome analysis showed this variant to be de novo in both siblings. The variant has not been previously reported in individuals with cortical dysplasia, complex, with other brain malformations 7 and was absent from large population studies. This variant has been reported in ClinVar (Variation ID: 1679255) and has been interpreted as likely pathogenic by Department of Clinical Genetics, Copenhagen University Hospital, Rigshospitalet. Computational prediction tools and conservation analyses suggest that this variant may impact the protein, though this information is not predictive enough to determine pathogenicity. The number of missense variants reported in TUBB2B in the general population is lower than expected, suggesting there is little benign variation in this gene and slightly increasing the possibility that a missense variant in this gene may not be tolerated. In summary, although additional studies are required to fully establish its clinical significance, this variant is likely pathogenic for autosomal dominant cortical dysplasia, complex, with other brain malformations 7. ACMG/AMP Criteria applied: PS2_Moderate, PM2_Supporting, PP3_Moderate, PP2 (Richards 2015).

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.